Beglyarova N.; Banina E.; Zhou Y.; Mukhamadeeva R.; Andrianov G.; Bobrov E.; Lysenko E.; Skobeleva N.; Gabitova L.; Restifo D.; Pressman M.; Serebriiskii I.; Hoffman J.; Paz K.; Behrens D.; Khazak V.; Jablonski S.; Golemis E.; Weiner L.; Astsaturov I.
(2016)
©2016 AACR.Purpose: Even when diagnosed prior to metastasis, pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy with almost 90% lethality, emphasizing the need for new therapies optimally targeting the ...